For NSCLC a downregulation of CDKN2A was reported [36] prooving that carcinoids use a similar way as NSCLC to drive G1/S-phase transition, instead cell cycle progression in LCNEC and SCLC is driven by the contrary pathway as summarized in Figure 3. This evidence concerns the gene CDKN2A and large cell neuroendocrine carcinoma.